Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain
- Rojo, F.
- Conde, E.
- Torres, H.
- Cabezón-Gutiérrez, L.
- Bautista, D.
- Ramos, I.
- Carcedo, D.
- Arrabal, N.
- García, J.F.
- Galán, R.
- Nadal, E.
Journal:
BMC Cancer
ISSN: 1471-2407
Year of publication: 2022
Volume: 22
Issue: 1
Type: Article